- Home
- BDTX vs TECH Comparison
BDTX vs TECH Comparison
Compare BDTX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- TECH
- Stock Information
- Founded
- BDTX 2014
- TECH 1976
- Country
- BDTX United States
- TECH United States
- Employees
- BDTX N/A
- TECH N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BDTX Health Care
- TECH Health Care
- Exchange
- BDTX Nasdaq
- TECH Nasdaq
- Market Cap
- BDTX 132.5M
- TECH 7.8B
- IPO Year
- BDTX 2020
- TECH 1989
- Fundamental
- Price
- BDTX $2.94
- TECH $53.10
- Analyst Decision
- BDTX Strong Buy
- TECH Buy
- Analyst Count
- BDTX 6
- TECH 12
- Target Price
- BDTX $14.83
- TECH $70.00
- AVG Volume (30 Days)
- BDTX 1.2M
- TECH 1.9M
- Earning Date
- BDTX 08-05-2025
- TECH 08-06-2025
- Dividend Yield
- BDTX N/A
- TECH 0.61%
- EPS Growth
- BDTX N/A
- TECH N/A
- EPS
- BDTX 0.09
- TECH 0.83
- Revenue
- BDTX $70,000,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- BDTX N/A
- TECH $7.07
- Revenue Next Year
- BDTX N/A
- TECH $5.72
- P/E Ratio
- BDTX $33.49
- TECH $63.45
- Revenue Growth
- BDTX N/A
- TECH 4.72
- 52 Week Low
- BDTX $1.20
- TECH $46.01
- 52 Week High
- BDTX $6.75
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- BDTX 70.75
- TECH 59.94
- Support Level
- BDTX $2.43
- TECH $50.97
- Resistance Level
- BDTX $2.72
- TECH $55.53
- Average True Range (ATR)
- BDTX 0.18
- TECH 2.07
- MACD
- BDTX 0.03
- TECH 0.24
- Stochastic Oscillator
- BDTX 93.66
- TECH 77.60
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.